Highlights

[PHARMA] QoQ Cumulative Quarter Result on 2017-06-30 [#2]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 16-Aug-2017
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2017
Quarter 30-Jun-2017  [#2]
Profit Trend QoQ -     50.31%    YoY -     -14.77%
Quarter Report


View:


Show?  QoQ % Horiz. %

Cumulative Quarter Result
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Revenue 617,923 2,323,960 1,710,764 1,136,261 618,294 2,189,022 1,606,206 -47.13%
  QoQ % -73.41% 35.84% 50.56% 83.77% -71.75% 36.29% -
  Horiz. % 38.47% 144.69% 106.51% 70.74% 38.49% 136.29% 100.00%
PBT 28,707 73,064 53,198 37,927 27,777 72,017 67,948 -43.73%
  QoQ % -60.71% 37.34% 40.26% 36.54% -61.43% 5.99% -
  Horiz. % 42.25% 107.53% 78.29% 55.82% 40.88% 105.99% 100.00%
Tax -11,118 -17,977 -20,299 -8,918 -8,519 -26,158 -21,189 -34.97%
  QoQ % 38.15% 11.44% -127.62% -4.68% 67.43% -23.45% -
  Horiz. % 52.47% 84.84% 95.80% 42.09% 40.20% 123.45% 100.00%
NP 17,589 55,087 32,899 29,009 19,258 45,859 46,759 -47.92%
  QoQ % -68.07% 67.44% 13.41% 50.63% -58.01% -1.92% -
  Horiz. % 37.62% 117.81% 70.36% 62.04% 41.19% 98.08% 100.00%
NP to SH 17,586 53,823 32,023 28,443 18,923 45,599 46,435 -47.69%
  QoQ % -67.33% 68.08% 12.59% 50.31% -58.50% -1.80% -
  Horiz. % 37.87% 115.91% 68.96% 61.25% 40.75% 98.20% 100.00%
Tax Rate 38.73 % 24.60 % 38.16 % 23.51 % 30.67 % 36.32 % 31.18 % 15.57%
  QoQ % 57.44% -35.53% 62.31% -23.35% -15.56% 16.48% -
  Horiz. % 124.21% 78.90% 122.39% 75.40% 98.36% 116.48% 100.00%
Total Cost 600,334 2,268,873 1,677,865 1,107,252 599,036 2,143,163 1,559,447 -47.11%
  QoQ % -73.54% 35.22% 51.53% 84.84% -72.05% 37.43% -
  Horiz. % 38.50% 145.49% 107.59% 71.00% 38.41% 137.43% 100.00%
Net Worth 524,838 526,888 531,892 541,894 544,360 531,169 530,907 -0.76%
  QoQ % -0.39% -0.94% -1.85% -0.45% 2.48% 0.05% -
  Horiz. % 98.86% 99.24% 100.19% 102.07% 102.53% 100.05% 100.00%
Dividend
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Div 12,991 49,314 33,729 20,742 10,368 41,457 33,667 -47.03%
  QoQ % -73.66% 46.21% 62.61% 100.05% -74.99% 23.14% -
  Horiz. % 38.59% 146.48% 100.19% 61.61% 30.80% 123.14% 100.00%
Div Payout % 73.87 % 91.62 % 105.33 % 72.93 % 54.79 % 90.92 % 72.50 % 1.26%
  QoQ % -19.37% -13.02% 44.43% 33.11% -39.74% 25.41% -
  Horiz. % 101.89% 126.37% 145.28% 100.59% 75.57% 125.41% 100.00%
Equity
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Net Worth 524,838 526,888 531,892 541,894 544,360 531,169 530,907 -0.76%
  QoQ % -0.39% -0.94% -1.85% -0.45% 2.48% 0.05% -
  Horiz. % 98.86% 99.24% 100.19% 102.07% 102.53% 100.05% 100.00%
NOSH 259,821 259,551 259,460 259,279 259,219 259,107 258,979 0.22%
  QoQ % 0.10% 0.04% 0.07% 0.02% 0.04% 0.05% -
  Horiz. % 100.32% 100.22% 100.19% 100.12% 100.09% 100.05% 100.00%
Ratio Analysis
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
NP Margin 2.85 % 2.37 % 1.92 % 2.55 % 3.11 % 2.09 % 2.91 % -1.38%
  QoQ % 20.25% 23.44% -24.71% -18.01% 48.80% -28.18% -
  Horiz. % 97.94% 81.44% 65.98% 87.63% 106.87% 71.82% 100.00%
ROE 3.35 % 10.22 % 6.02 % 5.25 % 3.48 % 8.58 % 8.75 % -47.30%
  QoQ % -67.22% 69.77% 14.67% 50.86% -59.44% -1.94% -
  Horiz. % 38.29% 116.80% 68.80% 60.00% 39.77% 98.06% 100.00%
Per Share
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
RPS 237.83 895.38 659.36 438.24 238.52 844.83 620.21 -47.25%
  QoQ % -73.44% 35.80% 50.46% 83.73% -71.77% 36.22% -
  Horiz. % 38.35% 144.37% 106.31% 70.66% 38.46% 136.22% 100.00%
EPS 6.77 20.74 12.34 10.97 7.30 17.60 17.93 -47.79%
  QoQ % -67.36% 68.07% 12.49% 50.27% -58.52% -1.84% -
  Horiz. % 37.76% 115.67% 68.82% 61.18% 40.71% 98.16% 100.00%
DPS 5.00 19.00 13.00 8.00 4.00 16.00 13.00 -47.14%
  QoQ % -73.68% 46.15% 62.50% 100.00% -75.00% 23.08% -
  Horiz. % 38.46% 146.15% 100.00% 61.54% 30.77% 123.08% 100.00%
NAPS 2.0200 2.0300 2.0500 2.0900 2.1000 2.0500 2.0500 -0.98%
  QoQ % -0.49% -0.98% -1.91% -0.48% 2.44% 0.00% -
  Horiz. % 98.54% 99.02% 100.00% 101.95% 102.44% 100.00% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,229
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
RPS 236.54 889.62 654.89 434.97 236.69 837.97 614.86 -47.14%
  QoQ % -73.41% 35.84% 50.56% 83.77% -71.75% 36.29% -
  Horiz. % 38.47% 144.69% 106.51% 70.74% 38.49% 136.29% 100.00%
EPS 6.73 20.60 12.26 10.89 7.24 17.46 17.78 -47.70%
  QoQ % -67.33% 68.03% 12.58% 50.41% -58.53% -1.80% -
  Horiz. % 37.85% 115.86% 68.95% 61.25% 40.72% 98.20% 100.00%
DPS 4.97 18.88 12.91 7.94 3.97 15.87 12.89 -47.06%
  QoQ % -73.68% 46.24% 62.59% 100.00% -74.98% 23.12% -
  Horiz. % 38.56% 146.47% 100.16% 61.60% 30.80% 123.12% 100.00%
NAPS 2.0091 2.0170 2.0361 2.0744 2.0838 2.0333 2.0323 -0.76%
  QoQ % -0.39% -0.94% -1.85% -0.45% 2.48% 0.05% -
  Horiz. % 98.86% 99.25% 100.19% 102.07% 102.53% 100.05% 100.00%
Price Multiplier on Financial Quarter End Date
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Date 30/03/18 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 30/09/16 -
Price 4.2800 4.6000 4.1400 4.5800 4.8900 5.3000 5.5800 -
P/RPS 1.80 0.51 0.63 1.05 2.05 0.63 0.90 58.81%
  QoQ % 252.94% -19.05% -40.00% -48.78% 225.40% -30.00% -
  Horiz. % 200.00% 56.67% 70.00% 116.67% 227.78% 70.00% 100.00%
P/EPS 63.23 22.18 33.54 41.75 66.99 30.12 31.12 60.49%
  QoQ % 185.08% -33.87% -19.66% -37.68% 122.41% -3.21% -
  Horiz. % 203.18% 71.27% 107.78% 134.16% 215.26% 96.79% 100.00%
EY 1.58 4.51 2.98 2.40 1.49 3.32 3.21 -37.69%
  QoQ % -64.97% 51.34% 24.17% 61.07% -55.12% 3.43% -
  Horiz. % 49.22% 140.50% 92.83% 74.77% 46.42% 103.43% 100.00%
DY 1.17 4.13 3.14 1.75 0.82 3.02 2.33 -36.85%
  QoQ % -71.67% 31.53% 79.43% 113.41% -72.85% 29.61% -
  Horiz. % 50.21% 177.25% 134.76% 75.11% 35.19% 129.61% 100.00%
P/NAPS 2.12 2.27 2.02 2.19 2.33 2.59 2.72 -15.32%
  QoQ % -6.61% 12.38% -7.76% -6.01% -10.04% -4.78% -
  Horiz. % 77.94% 83.46% 74.26% 80.51% 85.66% 95.22% 100.00%
Price Multiplier on Announcement Date
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Date 16/05/18 27/02/18 15/11/17 16/08/17 16/05/17 21/02/17 21/11/16 -
Price 4.0700 4.0400 3.8200 4.1900 4.7200 5.1200 5.7000 -
P/RPS 1.71 0.45 0.58 0.96 1.98 0.61 0.92 51.23%
  QoQ % 280.00% -22.41% -39.58% -51.52% 224.59% -33.70% -
  Horiz. % 185.87% 48.91% 63.04% 104.35% 215.22% 66.30% 100.00%
P/EPS 60.13 19.48 30.95 38.20 64.66 29.09 31.79 53.00%
  QoQ % 208.68% -37.06% -18.98% -40.92% 122.28% -8.49% -
  Horiz. % 189.15% 61.28% 97.36% 120.16% 203.40% 91.51% 100.00%
EY 1.66 5.13 3.23 2.62 1.55 3.44 3.15 -34.78%
  QoQ % -67.64% 58.82% 23.28% 69.03% -54.94% 9.21% -
  Horiz. % 52.70% 162.86% 102.54% 83.17% 49.21% 109.21% 100.00%
DY 1.23 4.70 3.40 1.91 0.85 3.13 2.28 -33.76%
  QoQ % -73.83% 38.24% 78.01% 124.71% -72.84% 37.28% -
  Horiz. % 53.95% 206.14% 149.12% 83.77% 37.28% 137.28% 100.00%
P/NAPS 2.01 1.99 1.86 2.00 2.25 2.50 2.78 -19.46%
  QoQ % 1.01% 6.99% -7.00% -11.11% -10.00% -10.07% -
  Horiz. % 72.30% 71.58% 66.91% 71.94% 80.94% 89.93% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


 

1987 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SCOMNET 0.880.00 
 KOTRA 1.860.00 
 UCREST 0.1350.00 
 PINEAPP 0.3550.00 
 PUC 0.0650.00 
 WILLOW 0.400.00 
 IRIS 0.1450.00 
 TOPGLOV-C60 0.1150.00 
 BTECH 0.210.00 
 3A 0.840.00 

TOP ARTICLES

1. GENM: A relook into Genting Malaysia from Profitability, Volume Spread Analysis and what’s Insiders Report are telling they are doing now ? TradeVSA - Case Study
2. WHY SCOMI ENERGY (7045) CAN FOLLOW CARIMIN AND GO UP 400% FROM ITS LOWS, Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
3. Beneficiary From National Fiberisation and Connectivity Plan ( NFCP ) : GPACKET, NETX, OCK, OPCOM, REDTONE Treasure seeker
4. [转贴] 明年不管你是做什麼行業的,都要看看這篇文章 Good Articles to Share
5. Loser HL analyst Chye Wen Fei rates Leong Hup buy, but cease coverage on Lay Hong. Herbert
6. LIIHEN 马来西亚家具行业的现状及发展 股天乐 成长投资
7. Who is Najib’s most-hated opponent in Pakatan? save malaysia!!!
8. Jaks Resources - 1200MW power to fire up Soon ! DK66
Partners & Brokers